Related by context. All words. (Click for frequent words.) 76 Thrombolysis 64 Peripheral Arterial 64 Acute Myocardial Infarction 64 Risk Stratification 64 Left Ventricular 64 symptomatic intracranial 63 Histologic 63 hemodynamic variables 63 Myocardial 62 Coronary Artery Bypass Graft 62 coronary stenosis 62 NYHA functional class 62 recurrent venous thromboembolism 62 carotid artery stenosis 62 multidetector computed tomography 62 rFVIIa 62 Occlusive Disease 62 Histological 62 Randomized Evaluation 62 carotid artery stenting CAS 62 postoperative complication 62 Carotid 62 Patency 62 NMIBC 61 artery stenosis 61 Myocardial Ischemia 61 Ejection Fraction 61 epoetin alpha 61 upper gastrointestinal bleeding 61 multicenter randomized controlled 61 bivalirudin monotherapy 61 bronchial hyperresponsiveness 61 Prospective Randomized 61 SYNTAX 61 Infarct 61 Doppler echocardiography 61 Atherosclerotic 61 Coronary Angiography 61 otamixaban 61 gastroduodenal 61 SGRQ 60 prospective multicenter study 60 RENAL 60 Clinical Outcome 60 myocardial viability 60 renal artery stenting 60 jugular venous 60 Angiographic 60 Carotid Revascularization Endarterectomy vs. 60 Ischemic 60 intracerebral 60 intraobserver 60 transcranial Doppler 60 Echocardiographic 60 transcranial Doppler ultrasound 60 LV ejection fraction 60 aspartate aminotransferase AST 60 morphometric vertebral fractures 60 ECASS 60 cardiac magnetic resonance 60 vertebrobasilar 60 myocardial necrosis 60 recurrent DVT 60 interobserver reliability 60 Fractional Flow Reserve 60 Transesophageal 60 STRIDE PD 60 intrathoracic 60 Patients Undergoing 60 Hypotension 60 recombinant tissue plasminogen 60 Visual Analogue Scale VAS 60 underwent coronary angiography 60 Intravitreal 60 Skin sterol 60 angiographically 60 Captopril 60 rt PA 60 postprocedure 60 deep venous thromboses 60 Adjunctive 60 symptomatic VTE 60 NIS LL 60 Acute Ischemic Stroke 60 Coronary CTA 60 transthoracic 59 Monitoring ABPM 59 hyperacute 59 cTnI 59 QT Prolongation 59 transabdominal 59 pretest probability 59 Fracture Risk 59 NIH CPSI 59 estimated glomerular filtration 59 interobserver 59 parenchymal 59 BPS IC 59 MDCT angiography 59 Montgomery Åsberg Depression 59 colorectal adenoma 59 nimodipine 59 aminotransferase ALT 59 Index CDAI 59 diagnostic angiography 59 Common Toxicity Criteria 59 nicardipine 59 Glasgow Coma Scale 59 Pegylated Liposomal Doxorubicin 59 Intravascular 59 nonfatal myocardial infarction MI 59 Postoperative 59 myocardial perfusion 59 pulmonary arterial 59 haematologic 59 tenecteplase 59 hepatic arterial 59 intraventricular 59 endobronchial 59 gastrointestinal perforation 59 Oral Fingolimod 59 CHADS2 59 NATRECOR ® 59 acute ischemia 59 Severity MSCS score 59 ß blockers 59 β blockers 59 Emboli 59 RE LY ® 59 Primary endpoints 59 intra arterial 59 cilostazol 59 cortical atrophy 59 echocardiographic 59 unfractionated heparin UFH 59 left ventricular LV 59 pretransplant 59 Functional Assessment 59 dyssynchrony 59 Renal Artery 59 Health Assessment Questionnaire 59 drug eluting stent implantation 58 ischemia driven 58 Nesiritide 58 alteplase 58 Cardiac Resynchronization 58 Carotid artery 58 Ischemic Stroke 58 aneurysmal subarachnoid hemorrhage 58 Diastolic 58 Alzheimer Disease Assessment 58 PRADAXA #mg 58 ascending aortic 58 deep vein thromboses 58 Lesion 58 preoperative PSA 58 endothelium dependent 58 gadolinium enhanced 58 haemodynamic 58 QRS interval 58 tirofiban 58 CIMZIA TM certolizumab pegol 58 Rating Scale BPRS 58 Subgroup analysis 58 rebleeding 58 intracoronary 58 descending thoracic 58 reinfarction 58 WOMAC pain 58 F FDG PET 58 pulmonary angiography 58 Visual Analog 58 myocardial infarct size 58 postoperative atrial fibrillation 58 Sonographic 58 cardiac perfusion 58 creatine kinase MB 58 thrombolytic therapy 58 Invasive Breast Cancer 58 nonfatal MI 58 NIHSS 58 RECIST Response Evaluation Criteria 58 imipramine Tofranil 58 prognostic variables 58 thrombotic complications 58 LV dysfunction 58 neurocognitive outcomes 58 carotid endarterectomy CEA 58 Visual Analogue Scale 58 Patients Receiving 58 venous thromboembolic disease 58 Doppler sonography 58 FDG-PET/CT 58 hemodynamic measurements 58 Main Outcome Measure 58 Pulmonary artery 58 cardioembolic stroke 58 diastolic pressures 58 computed tomography angiography 58 atrioventricular block 58 cerebral vasospasm 58 glomerular filtration rate 58 APACHE II 58 Fondaparinux 58 Left Ventricular Dysfunction 58 systemic hypotension 58 left ventricular dysfunction 58 Brief Psychiatric 58 alfuzosin 58 Fibromyalgia Impact Questionnaire 58 prospective nonrandomized 58 periprocedural 58 Aggressive Reduction 58 microvessel 58 Biphasic 58 calcaneal fractures 57 bullous 57 tissue oxygenation 57 intravascular hemolysis 57 ExTRACT TIMI 57 sacral nerve stimulation 57 silent ischemia 57 VerifyNow 57 Clinical Relevance 57 glomerular filtration 57 intraoperative complications 57 XIENCE V PROMUS Stent 57 MMP inhibitor 57 Duodenal 57 laser Doppler 57 abdominal computed tomography 57 sirolimus eluting stents 57 liver resection 57 reactive hyperemia 57 sonographically guided 57 Randomized Controlled Trials 57 Score TOS 57 Embolic 57 carotid artery blockage 57 ACUITY trial 57 underwent angiography 57 Histopathological 57 LVSD 57 Multiethnic Study 57 clevidipine 57 HRCT 57 lung nodule 57 intima media thickness 57 esophageal carcinoma 57 Global Impression CGI 57 Main Outcome Measures 57 paracentesis 57 Chronic Heart Failure 57 Acute Decompensated Heart Failure 57 pulmonary alveolar 57 Tumor Response 57 prespecified secondary 57 Preoperatively 57 cerebral ischemia 57 Hemodynamic 57 Diabetic Neuropathy 57 ETDRS 57 intact parathyroid hormone 57 binary restenosis 57 acute aortic dissection 57 Solid Tumors 57 retrospective cohort 57 Carotid Endarterectomy 57 RE LY 57 Intracoronary 57 Symptom Severity 57 nerve conduction velocity 57 FluCAM arm 57 bronchoalveolar lavage 57 angiography CTA 57 CDAI 57 Crohn Disease Activity 57 prolonged QT interval 57 Ventricular Tachycardia 57 thickness IMT 57 PROPATEN Bioactive Surface 57 carotid intima media 57 Val HeFT 57 Nebulized 57 MR Angiography 57 transient elastography 57 underwent resection 57 Orthostatic Hypotension 57 Neuropsychiatric Inventory NPI 57 Dyspnea 57 ‰ ¥ 57 Percutaneous Tibial Nerve Stimulation 57 left ventricular systolic 57 platelet reactivity 57 hemodynamic parameters 57 esophagogastric 57 dual endothelin receptor antagonist 57 DAS# CRP 57 ASIA Impairment 57 thromboembolic 57 COR Analyzer 57 Visual Analog Scale 57 intracerebral haemorrhage 57 multivariate Cox 57 vasospasm 57 invasive angiography 57 QIDS SR 57 HOMA IR 57 exhaled NO 57 Vascugel ® 57 Treatment Outcome 57 Mitral Valve 57 atherosclerotic renal artery stenosis 57 HIV HCV coinfected 57 electrophysiologic 57 chronic thromboembolic pulmonary 57 Pain Intensity 57 infarct size 57 serum estradiol 57 postoperative delirium 56 carotid IMT 56 non valvular atrial 56 perfusion defects 56 symptomatic carotid stenosis 56 surgically resected 56 preterm neonates 56 Histopathologic 56 semiquantitative 56 Cilostazol 56 Y BOCS 56 ultrasonographic 56 inotropic therapy 56 Bivalirudin 56 mL/min/#.# m 2 56 Cardiac Resynchronization Therapy 56 GORE TAG Device 56 Exacerbation 56 saphenous vein graft 56 parathyroidectomy 56 aneurysmal 56 Natalizumab 56 ischemic cardiomyopathy 56 Bosentan 56 dyspnoea 56 postoperative hemorrhage 56 digital subtraction angiography 56 myocardial uptake 56 Resolute stent 56 Postoperative complications 56 GP IIb IIIa inhibitors 56 NSABP B 56 prospectively evaluated 56 photocoagulation 56 Aggressive Drug Evaluation 56 induced sputum 56 Adenoma Prevention 56 cardiac repolarization 56 Severity Index PASI 56 invasive aspergillosis 56 hemodynamically significant 56 NAVISTAR R 56 CARE HF 56 everolimus eluting stents 56 bioavailable testosterone 56 HDRS 56 subanalysis 56 Diastolic Heart Failure 56 Coronary Artery Calcium 56 perioperatively 56 Secondary endpoints included 56 coronary intervention 56 inotropic agents 56 stent binary restenosis 56 B Cell Lymphoma 56 NICE SUGAR 56 ILLUSTRATE 56 cerebral oxygenation 56 Critical Limb Ischemia CLI 56 tracheal intubation 56 ADCS CGIC 56 CT Angiography 56 cerebrovascular events 56 Heart Failure Patients 56 brain parenchyma 56 left ventricular diastolic 56 activated partial thromboplastin 56 SYNTAX trial 56 cardiac tamponade 56 YMRS 56 ischemic complications 56 Psoriasis Area 56 Guideline Update 56 Common Terminology Criteria 56 pulmonary artery banding 56 ximelagatran 56 d dimer 56 N telopeptide 56 serum sodium levels 56 computed tomographic 56 Vertos II 56 Hemospan R 56 Ischaemic 56 Sentinel Lymph Node Biopsy 56 arterial occlusion 56 BENICAR HCT 56 argatroban 56 Contrast Agent 56 Optical Coherence Tomography 56 malignant ascites 56 CHARM Added 56 Electrophysiological 56 prospective multicenter randomized 56 systolic dysfunction 56 Predict Risk 56 histologically proven 56 chemoradiation therapy 56 immunochemical fecal occult 56 Intervention Trial 56 Randomized Study 56 lobar 56 retrospective observational study 56 Seattle Angina Questionnaire 56 multivessel disease 56 Lp PLA 2 56 glycoprotein IIb IIIa inhibitors 56 Scale PANSS 56 paricalcitol 56 milrinone 56 beta blocker therapy 56 Hypercholesterolemia 56 rosuvastatin #mg 56 oral anticoagulation 56 peritumoral 56 PLX STROKE targeting 56 FDG PET imaging 56 percutaneous interventions 56 DES implantation 56 nonrandomized 56 hepatorenal syndrome 56 EVEREST II 56 noninferior 56 myocardial revascularization 56 intima media thickness IMT 56 baseline LDH 56 ST Elevation Myocardial 56 refractory ischemia 56 acetabular fractures 56 Tasigna prolongs 56 intracranial stenosis 56 COPERNICUS 56 Albuminuria 56 Edge STudy 56 MULTAQ 56 acute coronary syndromes ACS 56 Major Adverse Cardiac 56 myocardial reperfusion 56 treat benign prostatic 56 Estrogen Receptor 56 endoscopic ultrasonography 56 antiplatelet medication 56 QTc prolongation 56 oral bisphosphonate 56 Montgomery Asberg Depression 56 β blocker 56 Stroke Scale NIHSS 56 thromboembolism 56 Subgroup Analysis 56 ipsilateral stroke 55 Adenomas 55 Pharmacodynamics 55 pharmacodynamic parameters 55 fibrillation AF 55 Brief Pain 55 NSTE ACS 55 mediated dilation 55 nephrotoxicity 55 VADT 55 Placebo Controlled Trial 55 meta regression 55 pulmonary capillary wedge 55 cystoid macular edema 55 Diabetic Foot Ulcer 55 histologic subtype 55 D dimer 55 Mean Symptom Complex 55 nadroparin 55 QRS duration 55 lactate dehydrogenase 55 recurrent glioblastoma multiforme 55 Hepatic Encephalopathy 55 Pain Rating Scale 55 ADAS cog 55 Lipoprotein 55 pleurodesis 55 renal biopsy 55 risk reducing salpingo 55 Renal dysfunction 55 aminotransferase 55 PROactive study 55 epididymal 55 arteriolar 55 intracranial bleeding 55 Kaplan Meier analysis 55 C Reactive Protein 55 hemorrhagic complications 55 nonischemic 55 Ancrod 55 bolus dose 55 Multicenter 55 tumor histology 55 PICSO ® 55 pleural effusions 55 Randomized Clinical Trial 55 Cardiogenic Shock 55 glycoprotein IIb IIIa inhibitor 55 aPTT 55 coronary CT angiography 55 atorvastatin #mg 55 ALA PDT 55 embolic stroke 55 EQ 5D 55 urodynamic 55 Severity Index 55 T1a 55 number NCT# ClinicalTrials.gov 55 zonisamide SR 55 CONTRAINDICATIONS 55 Symptom Checklist 55 diabetes mellitus DM 55 cTnT 55 stratifying patients 55 aneurysm rupture 55 phase IIIb 55 anthropometric measures 55 PHPT 55 spirometric 55 IOP lowering 55 antiarrhythmic drug 55 Secondary Hyperparathyroidism 55 Cerebrovascular Diseases 55 fluvastatin 55 undergone radical prostatectomy 55 histological subtype 55 nonvertebral fracture 55 ADHD Rating Scale 55 asthma exacerbation 55 interobserver agreement 55 tamponade 55 NATRECOR R 55 Ankle Brachial Index 55 thoracentesis 55 nasal symptom 55 Inventory BPI 55 diuretics beta blockers 55 Injury Severity Score 55 anastomotic leak 55 bi ventricular pacing 55 carotid plaque 55 enthesitis 55 4mg/kg 55 fosbretabulin 55 rtPA 55 duplex ultrasonography 55 Tiotropium 55 transfusion syndrome 55 Unfractionated Heparin 55 prospective observational cohort 55 cardiac troponin T 55 flecainide 55 Pharmacodynamic 55 MDRD 55 anticoagulant warfarin 55 #mg dosing 55 Vertebral 55 Embolization 55 sitaxsentan 55 variceal hemorrhage 55 Dilated Cardiomyopathy 55 post thrombotic syndrome 55 transurethral 55 postoperative morbidity 55 Cystatin C 55 retinal vein occlusion induced 55 Pulmonary Artery 55 Meta analyzes 55 nasal lavage 55 radiotherapy RT 55 ENGAGE AF TIMI 55 troponin T 55 debulking surgery 55 etomidate 55 functional mitral regurgitation 55 edifoligide 55 subscores 55 serum cortisol 55 tissue perfusion 55 vasopressor 55 acute peripheral arterial 55 INTEGRILIN R 55 Stable Angina 55 prospective randomized controlled 55 immunohistochemical 55 NIHSS score 55 Am J Cardiol 55 Respiratory Symptoms 55 death reinfarction 55 ezetimibe simvastatin 55 IMPACT DCM 55 Ocular Surface Disease 55 vitreous haze 55 Follicular Lymphoma 55 metastatic malignant 55 achieved statistical significance 55 clazosentan 55 postoperative mortality 55 prospective multicenter 55 ACE Inhibitors 55 International Prostate Symptom 55 Randomised 55 oncologic outcomes 55 Phase 2b Study 55 antithrombotic therapies 55 recurrent laryngeal nerve 55 Angioedema 55 cholestasis 55 leukocyte count 55 thromboembolic events 55 FDG PET scans 55 nondiabetic patients 55 PRECISE 55 coronary revascularization 55 Scale cognitive subscale 55 Oral Mucositis 55 glaucomatous 55 Electroencephalography 55 Contraindications 55 intradermal injections 55 trials RCTs 55 Antibiotic prophylaxis 55 guided percutaneous 55 Status Scale EDSS 55 antigen PSA levels 55 ventricular remodeling 55 methacholine challenge 55 International Prognostic Scoring 55 biopsy Gleason 55 PANSS total 55 interstitial fibrosis 55 Tomographic 55 Prognostic Index 55 graft patency 55 preoperatively 55 brachial artery flow 55 lactate dehydrogenase LDH 55 HeartNet 55 CYPHER R Sirolimus eluting 55 CHAMPION PCI 55 Hyperlipidemia 55 Secondary endpoints 55 fundus photography 55 Systolic Blood Pressure 55 Rating Scale MADRS 55 icatibant 55 renal cysts 55 Scale EDSS 55 AST ALT 54 Coronary artery bypass graft 54 chronic subdural hematoma 54 randomized Phase IIb 54 HeFH 54 plasma renin activity 54 heparin induced thrombocytopenia 54 ARB telmisartan 54 longitudinal cohort study 54 OSDI 54 Benign Prostatic Hyperplasia 54 univariate 54 Pelvic Organ Prolapse 54 complement inhibitor eculizumab 54 renal pelvis 54 ISAR TEST 54 prospectively defined 54 plasma creatinine 54 subtrochanteric 54 Ventricular Arrhythmias 54 mineral density BMD 54 plasma pharmacokinetics 54 ACTOS ® 54 concomitant medications 54 QTcF 54 Radiofrequency Ablation 54 aspirin clopidogrel 54 aspartate aminotransferase 54 underwent CABG 54 RE LY trial 54 Interferon Alfa 54 nodal metastasis 54 plasma lipids 54 Prognostic significance 54 PEG IFN 54 bone scintigraphy 54 urine albumin 54 diabetic polyneuropathy 54 waist circumference WC 54 PCWP 54 pulmonary artery catheter 54 ml min 54 Doppler ultrasonography 54 Score DAS 54 CK MB 54 moderately emetogenic 54 statistically significant p = 54 Radiation Dose 54 MYCAMINE 54 Biolimus A9 54 Embolic Protection System 54 grade squamous intraepithelial 54 Rating Scale UPDRS 54 Aneurysm Repair 54 HGPIN 54 myocardial fibrosis 54 HPA axis suppression 54 radioimmunoassay 54 Is Well Tolerated 54 Microalbuminuria 54 serum phosphorous 54 coagulation abnormalities 54 prospective multicentre 54 Multicenter Study 54 Papillary 54 color Doppler sonography 54 Prolongs Survival 54 #Gy 54 RECORD1 54 Systemic Lupus Erythematosus 54 percutaneous injection 54 Plasma concentrations 54 zoledronate 54 NYHA 54 echocardiographic parameters 54 calculi 54 Dysmenorrhea 54 adenomatous 54 multiple logistic regression 54 mesilate 54 multicenter prospective 54 CLINICAL PHARMACOLOGY 54 ASTEROID 54 Cardiotoxicity 54 Refractory Angina 54 BMI z 54 Aortic Valve 54 modified REGENESIS Phase IIb 54 antithrombotic therapy 54 prostate cancer PCa 54 bivalirudin alone 54 Dacogen decitabine 54 inflammatory biomarkers 54 aminotransferases 54 conjugated estrogens 54 IIIb 54 triiodothyronine 54 carotid artery intima media 54 nitroprusside 54 ^ sup #m 54 intravascular ultrasonography 54 revascularizations 54 HER2 expression 54 clinically meaningful improvement 54 Prophylactic Treatment 54 Carotid Artery Stenting 54 ug dose 54 ST Segment Elevation 54 diastolic blood pressures 54 Alteplase 54 Tranexamic acid 54 UPDRS 54 Solid Tumours 54 diffusion tensor 54 Postoperatively 54 Multidetector CT 54 microcirculatory 54 mediastinal 54 Carotid endarterectomy 54 surgically induced 54 coronary artery occlusion 54 fractional shortening 54 Cypher Sirolimus 54 Brain Metastases 54 Parathyroid Hormone 54 liver histology 54 Teriparatide 54 ATACAND 54 prospectively randomized 54 diagnosing coronary artery 54 dimeglumine 54 leukocyte counts 54 antiarrhythmic 54 conventional angiography 54 Hypertrophy 54 Proteinuria 54 QuadraSphere 54 artery elasticity 54 Catheter Ablation 54 bronchogenic carcinoma 54 plasma cortisol 54 esophagogastroduodenoscopy 54 NCT# ClinicalTrials.gov 54 knee osteoarthritis OA 54 AMI acute myocardial 54 BEXXAR Therapeutic Regimen 54 Glomerular filtration rate 54 extracranial 54 multivariable analysis 54 corneal inlay 54 platelet inhibition 54 obstructive CAD 54 binary logistic regression 54 eplerenone 54 QT intervals 54 AUC0 54 HCV Genotype 54 Intra arterial 54 hypertension PAH 54 MADIT II 54 revascularisation procedures 54 morphometry 54 Myocardial Perfusion 54 WallFlex Biliary RX 54 DCE MRI 54 sternal wound infections 54 Infusion Reactions Severe 54 Angiotensin Converting Enzyme 54 Chronic Renal Failure 54 esophageal manometry 54 bivariate analysis 54 EtCO2 54 HRQL 54 CT perfusion 54 CTEPH 54 Differential Diagnosis 54 Diabetic Nephropathy 54 biochemical relapse 54 endoscopic resection 54 lavage fluid 54 Mycophenolate Mofetil 54 estimated GFR 54 Negative Symptoms 54 UPDRS motor 54 CHADS 54 prospectively stratified 54 ^ Tc 54 thyrotropin levels 54 hemostatic efficacy 54 serum urate levels 54 Septic Shock 54 WOMAC scores 54 electroencephalographic 54 Non Alcoholic Steatohepatitis 54 Xelox 54 NPRS 54 Glomerular Filtration Rate 54 interferon ribavirin 54 Hematologic 54 titrated glipizide 54 Cholinesterase Inhibitors 54 QD dosing 54 atrophic vaginitis 54 Endarterectomy 54 aldosterone antagonist 54 coagulation parameters 54 mild renal insufficiency 54 retrospectively analyzed 54 eculizumab therapy 54 extrapyramidal symptoms 54 SUVmax 54 hyperprolactinemia 54 pT2 54 revascularisation 54 pentoxifylline 54 pulmonary resection 54 System IPSS 54 physiologic parameters 54 gadolinium enhancing 54 DVT prophylaxis 54 urothelial cancer 54 glycated hemoglobin levels 54 platelet dysfunction 54 dobutamine 54 carotid atherosclerosis 53 oropharyngeal 53 Kruskal Wallis test 53 Trandolapril 53 hMG 53 dissolving blood clots 53 abacavir Ziagen 53 piroxicam 53 Severe Sepsis 53 Anticoagulants 53 bronchoalveolar lavage BAL 53 prospective longitudinal 53 Percutaneous Transluminal Coronary Angioplasty 53 D Dimer 53 steroid dexamethasone 53 underwent surgical resection 53 vWD 53 Pooled Analysis 53 International Normalized Ratio 53 lumbar spine bone 53 Deep venous thrombosis 53 serum aminotransferase levels 53 Stroke Scale 53 LNG IUS 53 logistic regression analysis 53 efaproxiral 53 oxycodone CR 53 intradiscal 53 ABCB1 53 femoral neck fracture 53 MGd 53 Renal Function 53 % CI #.#-#.# [008] 53 distal radial fractures 53 Physiologic 53 incomplete revascularization 53 treated nonoperatively 53 multivariable adjusted 53 ventricular tachyarrhythmia 53 midazolam Versed 53 multivariate logistic regression 53 pain palliation 53 arterial elasticity 53 Dyslipidemia 53 calcified plaques 53 demonstrated clinically meaningful 53 AGHD 53 SF #v# 53 GI bleeds 53 Legg Calvé Perthes disease 53 prostate carcinoma 53 galiximab 53 riociguat 53 prasugrel Effient 53 P = .# 53 ADAS Cog 53 Sirolimus eluting 53 Disease Activity 53 Esophageal 53 angiographic outcomes 53 arterial oxygen saturation 53 autonomic dysfunction 53 tertile 53 histopathologic 53 preintervention 53 specific antigen PSA 53 thyrotropin 53 plus 5-FU/LV 53 urodynamic parameters 53 hyperhomocysteinemia 53 immunohistochemical analysis 53 Hormone Refractory Prostate Cancer 53 Mitomycin C 53 thiazide 53 neurologic deficits 53 Myelodysplastic Syndrome MDS 53 calculated creatinine clearance 53 dalteparin 53 nerve conduction velocity NCV 53 randomized multicenter 53 AGGRASTAT R Injection tirofiban 53 VATS lobectomy 53 papillary renal cell carcinoma 53 Helicobacter pylori eradication 53 Multivariate logistic regression 53 Daxor BVA 53 PressureWire 53 carotid revascularization 53 magnetic resonance CMR 53 coronary computed tomography 53 clinicopathologic 53 metastatic neuroendocrine tumors 53 hyperintensities 53 Patients Treated With 53 Statistically Significant 53 macrovascular disease 53 Score IPSS 53 Replacement Therapy 53 CardioPass 53 MIST II 53 Pharmacokinetics PK 53 epoetin therapy 53 mitral valve regurgitation 53 Aortic Stenosis 53 Clinician Administered PTSD 53 polytherapy 53 CIN2 + 53 Elderly Patients 53 Knee Osteoarthritis 53 shock wave lithotripsy